Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $11,654.00 |
|---|---|
| Enterprise Value | $6.03 Million |
| Earnings per Share | $-0.27 |
| Beta | 6.4 |
| Outstanding Shares | 116,536,380 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.58 |
| Enterprise Value to EBIT | -21.51 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.22 |
| Debt to Equity | 0.52 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
RxElite, Inc. is a pharmaceutical company that specializes in the development, production, and commercialization of generic prescription drugs, particularly within specialty markets. Its diverse product portfolio encompasses Sterile Liqu...